Erratum: Novel role of gp91phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. (Circulation Research 2002;91:(1160-1167)) DOI: 10.1161/01.RES.0000046227.65158.F8;Novel role of gp91phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis

Circulation Research

Volumn 91, Issue 12, 2002, Pages 1160-1167

  Ushio Fukai, Masuko ^a   Tang, Yan ^a   Fukai, Tohru ^a   Dikalov, Sergey I ^a   Ma, Yuxian ^a   Fujimoto, Mitsuaki ^a   Quinn, Mark T ^b   Pagano, Patrick J ^c   Johnson, Chad ^a   Alexander, R Wayne ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

Angiogenesis; Endothelial cells; NAD(P)H oxidase; Reactive oxygen species; Vascular endothelial growth factor

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ANTISENSE OLIGONUCLEOTIDE; ENZYME INHIBITOR; GLYCOPROTEIN; GLYCOPROTEIN GP 91; OXYGEN; PROTEIN TYROSINE KINASE; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 0036954803     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/01.res.0000441275.92652.60     Document Type: Erratum

References (29)

1. Matsumoto T, Claesson-Welsh L. VEGF receptor signal transduction. Science STKE. 2001;112;1-12.
2. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
3. Yasuda M, Ohzeki Y,. Shimizu S, Naito S, Ohtsuru A, Yamamoto T, Kuroiwa Y. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-l in endothelial cells. Life Sci. 1999;64: 249-258.
4. Lelkes PI, Hahn KL, Sukovich DA, Karmiol S, Schmidt DH. On the possible role of reactive oxygen species in angiogenesis. Adv Exp Med Biol. 1998;454:295-310.
5. Ellis EA, Guberski DL, Somogyi-Mann M, Grant MB. Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med. 2000;28:91-101.
6. Ruef J, Hu ZY, Yin LY, Wu Y, Hanson SR, Kelly AB, et al. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. Circ Res. 1997;81:24-33.
7. Babior BM. The NADPH oxidase of endothelial cells. IUBMB Life. 2000;50:267-269.
8. Abid MR, Kachra Z, Spokes KC, Aird WC. NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett. 2000;486:252-256.
9. Quinn MT, Evans T, Loetterle LR, Jesaitis AJ, Bokoch GM. Translocation of Rac correlates with NADPH oxidase activation. Evidence for equimolar translocation of oxidase components. J Biol Chem. 1993;268: 20983-20987.
10. phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res. 2000;87:26-32.
11. Pyne S, Pyne N. Sphingosine l-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors. Pharmacol Ther. 2000;88:115-131.
12. Dikalov SI, Dikalova AE, Mason RP. Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine. Arch Biochem Biophys. 2002;402:218-226.
13. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. p38 MAP kinase is a critical component of the redox-sensitive signaling pathways by angiotensin II: Role in vascular smooth muscle cell hypertrophy. J Biol Chem. 1998;273:15022-15029.
14. Kim KS, Takeda K, Sethi R, Pracyk JB. Tanaka K, Zhou YF, Yu ZX, Ferrans VJ, Bruder JT, Kovesdi I, Irani K, Goldschmidt-Clermont P, Finkel T. Protection from reoxygenation injury by inhibition of rac1. J Clin Invest. 1998;101:1821-1826.
15. phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: Regulation by angiotensin II. Circ Res. 2002;90: 1205-1213.
16. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, Fisherman J, Orkin SH. Doerschuk CM, Dinauer MC. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet. 1995;9:202-209.
17. Andrade SP, Cardoso CC, Machado RD, Beraldo WT. AngiotensinII-induced angiogenesis in sponge implants in mice. Int J Microcirc Clin Exp. 1996;16:302-307.
18. Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxysubstituted catechol. Am J Respir Cell Mol Biol. 1994;11:95-102.
19. Diatchuk V, Lotan O, Koshkin V, Wikstroem P, Pick E. Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem. 1997;272:13292-13301.
20. .- in vascular smooth muscle cells. Circ Res. 1995;77:29-36.
21. Abid MR, Tsai JC, Spokes KC, Deshpande SS, Irani K, Aird WC. Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Racl-regulated NADPH oxidase-dependent mechanism. FASEB J. 2001;15:2548-2550.
22. Colavitti R. Pani G, Bedogni B. Anzevino R, Borrello S, Waltenberger J, et al. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem. 2002;277:3101-3108.
23. Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kB and induces monocyte chemoattractant protein-l in bovine retinal endothelial cells. Diabetes. 1999;48: 1131-1137.
24. Lambeth JD, Cheng G, Arnold R, Edens WA. Novel homologs of gp91 phox. Trend Biochem Sci. 2000;25:459-461.
25. Joneson T, Bar-Sagi D. A Rac1 effector site controlling mitogenesis through superoxide production, J Biol Chem. 1998;273:17991-17994.
26. Moldovan L, Irani K, Moldovan NI, Finkel T, Goldschmidt-Clermont PJ. The actin cytoskeleton reorganization induced by Rac1 requires the production of superoxide. Antioxid Redox Signal. 1999;1:29-43.
27. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, Alexander RW. Epidermal growth factor receptor transactivation by angiotensin 1I requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001;21:489-495.
28. Finkel T. Signal transduction by reactive oxygen species in nonphagocytic cells. J Leukoc Biol. 1999;65:337-340.
29. Burritt JB, Quinn MT, Jutila MA, Bond CW, Jesaitis AJ. Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries. J Biol Chem. 1995;270:16974-16980.